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Objectives The goal of this study was to examine the safety and results of interventional proce-
dures performed during the broadcast of live case demonstrations.
Background Professional meetings using live case demonstrations to present cutting-edge technol-
ogy are considered a valuable educational resource. There is an ongoing discussion on whether pa-
tients who are treated during live case demonstrations are exposed to a higher risk.
Methods Between 1998 and 2010, 101 patients were treated during live transmissions from a single
center in 15 invasive-cardiology conferences. Technical success was deﬁned as the ability to effec-
tively perform the planned procedure without any major complication. The primary endpoint of the
study was the composite occurrence of death, myocardial infarction, or stroke.
Results The interventional procedures included coronary (n  66), carotid (n  15), peripheral (n  1),
valvular (n  2), congenital heart disease (n  12), and complex electrophysiological mapping and
ablation interventions (n  7). In 4 cases, the intended procedure was not done. The procedure was
technically successful in 95%. In 5 cases, the procedure was unsuccessful because of the inability to
cross a chronic total occlusion. There were no deaths during the hospital stay, and the composite
primary endpoint occurred in 2 patients: a minor stroke following an atrial ﬁbrillation ablation and a
rise in serum troponin levels after percutaneous coronary intervention. These results were no differ-
ent from those of 66 matched controls who underwent procedures performed by the same opera-
tors but not as live case demonstrations (relative risk: 0.32; 95% conﬁdence interval: 0.02 to 3.62,
p  0.62).
Conclusions In this consecutive series of interventional cardiology procedures that were performed
by expert operators during live demonstration courses, the procedural and 30-day clinical outcomes
were similar to those found in daily practice and to those that have been reported in the contem-
porary published data. These results suggest that broadcasting live case demonstrations in selected
patients from selected centers may be safe. (J Am Coll Cardiol Intv 2012;5:215–24) © 2012 by the
American College of Cardiology Foundation
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216The number of transcatheter cardiovascular interventions
has increased dramatically and the technique has improved
significantly during the past decades. Newer and better
devices, improved pharmacological treatments, and en-
hanced visualization, guidance, and monitoring now enable
a safer and more efficacious procedure. As a result, the
periprocedural event rate has fallen over the past years (1,2).
See pages 225 and 228
The training in interventional cardiology involves di-
rect mentoring by experienced cardiologists during an
actual clinical procedure, as well as learning from peers
during professional meetings and focused courses. Rapid
advances in technology, the demand to improve quality
and safety, and the dissemination of information on new
tools, equipment, and state-of-the-art interventional tech-
niques have led to the develop-
ment of courses with live case
demonstrations around the world
for dissemination of information
and training purposes.
The growth in the number of
meetings with live case demonstra-
tions of interventional procedures is
true not only in cardiology, but also
in surgery, gastroenterology, and
other medical disciplines. In cardi-
ology, the procedure is performed in
the catheterization laboratory and is
transmitted to a conference hall,
which can be in the same medical
center, but often is at another loca-
tion on the globe.
It is assumed that during live
case demonstrations, the oper-
ators perform the procedure in a more stressful environ-
ment than in daily routine work. There are cameras and
production personnel in the catheterization laboratory,
and an expert panel in the conference hall interacts with
the operator and team, discusses the case, and advises
what they think should be done. Every step of the
procedure is broadcast onto large screens. Frequently,
novel devices are used, and the cases that are chosen
for the demonstration are exceptionally challenging be-
cause the “regular” cases are not as educational or informa-
tive. The operator and the team are required to discuss their
plans and rationale with the panel or the audience while still
in the midst of the procedure. Thus, the operator and the
team have to deal, not only with a complex procedure, but
also with an expert panel that may often criticize the
interventional plan, and may even suggest an alternative
Abbreviations
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CI  confidence interval
CTO  chronic total
occlusion
EP  electrophysiological
FDA  Food and Drug
Administration
MCRS  Mayo Clinic
Risk Score
MI  myocardial infarction
PCI  percutaneous
coronary intervention
RR  relative risk
VF  ventricular fibrillation
VT  ventricular tachycardiaapproach.There has been an ongoing discussion about the ethics of
live demonstration and the patient safety of these proce-
dures from the early days of live demonstration broadcasts of
interventional procedures (3–10). Despite the increasing
use of this educational modality in medical meetings,
there are only 2 published reports that have investigated
the patients’ safety during live case demonstration in
transcatheter therapeutics: 1 report from 1992 on coro-
nary procedures, and a second report from 2009 on
carotid interventions (4,5). Therefore, we sought to
examine the results of transcatheter cardiovascular pro-
cedures that were performed during live demonstration
transmissions at our center since 1998.
Methods
This study was performed in compliance with the local
human studies committee. The study is comprised of all
patients in whom a procedure was attempted and transmit-
ted live to interventional cardiology conferences, which our
center organized or participated in between 1998 and 2010.
The primary operators were experienced cardiologists from
our center and, in only a few cases, international guest
operators. Overall, 8 primary operators participated in
coronary procedures, 2 operators in pediatric procedures,
and 4 in electrophysiological (EP) procedures. In all cases, 1
or 2 additional secondary operators participated. The med-
ical conferences were international and national. Written
informed consent for treatment and live transmission of the
procedure was received from all patients before the proce-
dure. The procedure was performed in the standard way,
and all medications were given in the customary manner.
The operators were connected to microphones, and the
filming staff was present in the room. The operators
discussed each step of the procedure and responded to the
many comments of the expert panel. The discussion took
place before the procedure was done, during the procedure,
and after completion. In the annual local meetings, which
have been organized by our center since 1998, there were
parallel transmissions of live demonstrations from 3 cathe-
terization laboratories. In these cases, the operators needed
to pause according to the scheduled transmission slot.
Hence, some of these procedures took longer than usual to
complete. In all these cases, patient safety was always the top
priority. When scheduling caused a significant delay, parts
of the procedure were not transmitted live, and the proce-
dure presentation, as well as the discussion, were done at the
end of the procedure.
Data were collected from the medical records, procedure
notes, catheterization films, conference programs, live case
schedules, and follow-up visits.
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217Definitions
Successful intervention. A procedure was defined as suc-
cessful when the intended goals were achieved and the
procedure was completed in the absence of any major
complications.
Partial success. If the intended coronary procedure involved
he treatment of multiple lesions, and not all planned lesions
ere eventually treated, the procedure was classified as being
artially successful. For example, if 4 lesions were planned
o be stented during the live demonstration, and not all of
he lesions were treated, the procedure was defined as being
artially successful.
Major complications and the primary and secondary endpoints.
The primary endpoint was the composite of all-cause death,
myocardial infarction (MI), and stroke. The secondary
endpoints were death, MI, stroke, or repeat procedure
within 30 days after the first procedure.
Diagnosis of MI. The diagnosis was based on the definition
at the time of the intervention and was based on the joint
definition of the European Society of Cardiology/American
College of Cardiology for acute MI in 2000, then adapted to
the definition of European Society of Cardiology/American
College of Cardiology Foundation/American Heart Asso-
ciation/World Heart Federation in 2007 (11,12).
Elevations of troponin above the 99th percentile of the
upper reference limit after percutaneous coronary interven-
tion (PCI), assuming a normal baseline value, indicated
post-procedural myocardial necrosis for noncoronary proce-
dures. Increases more than 3 times the 99th percentile of the
upper reference limit were classified as PCI-related MI
(type 4a). MI was determined according to the change of
troponin together with at least 1 of the following: symptoms
of ischemia; electrocardiographic changes indicative of new
ischemia (new ST-T changes or new left bundle branch
block) or new left bundle branch block; development of
pathological Q waves in the electrocardiogram; imaging
evidence of new loss of viable myocardium or new regional
wall motion abnormality.
Minor complications. These were defined as any result or
vent that occurred during or after the procedure that was
nexpected or unwanted, such as vessel closure, signifi-
ant arrhythmias, perforations, tamponade, need for ur-
ent surgery, access site complications, and hemodynamic
nstability.
Control Group and Statistical Methods
The number of EP and congenital abnormalities procedures
is small, and thus it is difficult to compare the outcomes of
these patients to parallel routine cases. We compared our
coronary patients treated during live transmission (n  66)
to our daily experience during 1 year (n  2,039) and to a
matched control group (n  66).The following variables were used for matching the
control group: extent of coronary artery disease, anginal
status, age, sex, and hyperlipidemia. Data are expressed as
mean  SD. Baseline characteristics of the groups were
compared using unpaired t test for continuous variables and
by the chi-square statistic for noncontiguous variables. A
2-sided exact Fisher-Irwin test with a 5% significance level
was applied for comparison of specific events between the
groups. The relative risk (RR) and 95% confidence intervals
(CI) comparing the live case demonstration group and the 2
control groups were determined. All statistical analyses were
performed using the SPSS statistical software (Version 15.0,
IBM, Armonk, New York).
Results
Between 1998 and 2010, we identified 120 patients at our
center who were scheduled for live case transmission during
15 interventional conferences. Because of time constraints
or schedule changes due to urgent cases during the meet-
ings, 19 live cases were not done at the scheduled time, but
were treated later on the same day or the next day.
Table 1. Procedures Performed During Live Transmissions
Coronary procedures 66
Carotid procedures 13
ICA 10
CCA 2
Aborted 1
Congenital heart procedures 12
ASD closure 4
PFO closure 3
VSD closure 2
PDA closure 2
COA angioplasty 1
EP procedures 7
Ablation of VPBs/short VT of RV outﬂow 2
Ablation of foci of PAF around PV 2
Ablation of EP foci originating in scar 1
EPS mapping to detect right ventricular dysplasia 1
Ablation using Carto mapping for SVT 1
Stent insertion in subclavian artery 1
Combined coronary and pediatric procedure:
stent insertion into RCA with ASD occlusion
1
Combined coronary and carotid procedures 2
Stenting of LAD with stenting of LCCA 1
Stenting of RCA with stenting of RICA 1
Transcatheter aortic valve implantation 2
ASD  atrial septal defect; CCA  right common carotid artery; COA  coarctaion of
aorta; EP electrophysiology; EPS electrophysilogic study; ICA internal carotid artery; LAD
left anteriordescendingcoronaryartery;LCCA leftcommoncarotidartery;LV leftventricle;PAF
paroxysmal atrial fibrilation; PDA  patent ductus arteriosus; PFO  patent foramen ovale; PV 
pulmonary veins; RCA  right coronary artery; RICA  right internal carotid artery; RV  right
ventricle; SVT  supraventricular tachycardia; VPBs  ventricular premature beats; VSD  ven-tricular septal defect; VT ventricular tachycardia.
E
v
s
p
a
s
w
a
a
i
w
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S , V O L . 5 , N O . 2 , 2 0 1 2
F E B R U A R Y 2 0 1 2 : 2 1 5 – 2 4
Eliyahu et al.
Safety of Live Case Demonstration
218Therefore, our study population comprised 101 patients
in whom the procedure was done during a live transmission.
The age of the patients ranged from 5 to 86 years (62  14
years), and 21 (21%) were females. Table 1 summarizes the
interventional procedures, which consisted of a range of
coronary interventions, carotid stenting, valvular interven-
tions, congenital heart diseases, and EP interventions.
Sixty-six patients (66%) underwent coronary interventions.
We performed a combined coronary and congenital heart
defect procedure in 1 patient, and a combined coronary and
carotid procedure in 2 patients.
The clinical characteristics of the patients that underwent
coronary interventions are presented in Table 2. The ma-
jority of patients were smokers and had hypertension and
hyperlipidemia. The target vessels of the planned coronary
procedures are detailed in Table 3. Sixty-two percent of the
coronary patients had multivessel disease, and the left
anterior descending coronary artery was involved in 48%.
Major Complications
The rate of major complications was 2 of 101 (2%). There
were no deaths during the procedure or during the hospital
stay. In 1 patient following PCI, the serum troponin levels
increased above the upper reference limit, and the patient
was classified as having a PCI-related MI (type 4a) (11).
There was 1 case of a stroke in a 61-year-old patient who
underwent pulmonary vein isolation for atrial fibrillation.
Following the EP ablation, a disturbance in the patient’s
speech and a right hemiparesis appeared. Brain computed
tomography did not demonstrate cerebral bleeding. The
patient was discharged with a mild disturbance of speech,
which had completely resolved at follow-up.
Procedure Completion and Success Rate
Of the 101 live transmitted procedures, 4 patients were not
treated after the angiography (Fig. 1). In a 72-year-old man
with an ST-segment elevation MI scheduled for PCI
intended to be transmitted live, coronary angiography dem-
onstrated 3-vessel coronary artery disease, and the operators
and the expert panel decided not to proceed with PCI, and
instead referred the patient for coronary artery bypass
surgery. A planned carotid procedure was not done because
the stenosis previously diagnosed by Doppler in the left
internal carotid artery was proven to be in the left external
carotid artery after several angiographic views. An EP proce-
dure was not continued in a 52-year-old man who was
scheduled for right ventricular outflow tract tachycardia abla-
tion because ventricular premature beats could not be provoked
even after an aggressive pacing induction protocol. A second
P procedure was aborted in a 25-year-old patient with right
entricular dysplasia that was referred for ablation, because 2
ources of ventricular tachycardia (VT) were identified, and it was cdecided to treat the patient with an implantable cardioverter-
defibrillator rather than with the intended ablation.
Intervention success. The overall success rate was 95% (in
92 of 97 procedures attempted). However 8 procedures (8%)
were classified as being partially successful, 6 of these partial
successes were coronary interventions (Online Table 1).
Thus, in 83% of patients, the procedure was classified as
successful by our strict definition of intended procedure com-
pleted fully and in the absence of any major complications.
Five procedures, all of them with coronary interventions,
were classified as being unsuccessful. All were cases of
chronic total occlusions (CTOs) with failure to cross the
lesion with either a guidewire or a balloon catheter. Overall,
10 CTOs were attempted, and the success rate in this type
of lesion was 50%.
Minor Complications and Other Events
Among the 66 coronary procedures, there were 3 cases of
ventricular fibrillation (VF) that were successfully converted
to sinus rhythm using direct current shock, and 1 case of
guidewire-induced coronary artery perforation that was
clinically uneventful. Post-procedural complications in-
cluded 2 access site bleedings. There was a tamponade
during a congenital heart disease procedure, which was
treated successfully with pericardiocentesis in the catheter-
ization laboratory, and 1 access site complication.
Other minor events included 2 cases of vasovagal reac-
tions with prolonged hypotension, 4 cases of type B or C
dissections of a coronary vessel, allergic reaction (n  1),
and hypertension (n  1).
Among the patients undergoing EP procedures there was
1 case of complication in a 72-year-old man who was
treated for ventricular premature beats that originated from
an inferoposterolateral scar. After induction of VT (160
beats/min), the heart rate deteriorated to rapid VT (220
beats/min) with loss of consciousness, and an electrical
shock for cardioversion was required. During carotid angio-
plasty there were 2 cases of vasovagal reactions.
Follow-Up
1 month. During the 30-day follow-up available for all
atients, there were no deaths or strokes; repeat coronary
ngiography was performed in 2 patients: 1 patient with
tent thrombosis and another patient with chest pain and
ithout any angiographic findings.
1 year. One-year follow-up was available for all patients,
nd no deaths, strokes, or MIs were reported. Coronary
ngiography was performed in 1 additional patient, but no
ntervention was needed. Routine angiographic follow up
as not performed in any patient. There were no cases oflinical restenosis.
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219Table 2. Patient Characteristics
Live
Transmission
(n  66)
Matched
Controls
(n  66)
p Value vs.
Matched
Routine
(2010 Cohort)
(n  2,039)
p Value vs.
Routine
Sex 0.82 0.31
Male 53 (80) 55 (83) 1,525 (75)
Female 13 (20) 11 (17) 514 (25)
Age, yrs 0.71 0.75
49 8 (12) 6 (9) 324 (16)
50–59 17 (26) 22 (33) 573 (28)
60–69 24 (36) 15 (23) 613 (30)
70 17 (26) 23 (35) 529 (26)
Risk factors
Current smokers 17 (26) 15 (23) 0.84 501 (25) 0.82
History of smoking 24 (36) 17 (26) 0.26 858 (42) 0.35
Hypertension 45 (68) 47 (71) 0.85 1,204 (59) 0.13
Renal dysfunction 7 (11) 6 (10) 0.91 122 (6) 0.12
Diabetes 23 (35) 23 (35) 1.00 695 (34) 0.97
Hypelipidemia 52 (79) 51 (77) 0.83 988 (48) 0.03
Family history of IHD 18 (27) 16 (24) 0.84 371 (18) 0.07
Vessel disease
1VD 24 (36) 25 (38) 0.92 518 (33) 0.52
2VD 22 (33) 22 (33) 1.00 496 (31) 0.71
3VD 19 (29) 19 (29) 1.00 443 (28) 0.86
LMCA involvement 3 (5) 0 (0) 0.97 134 (8) 0.81
Symptoms
Stable angina pectoris 27 (41) 38 (57) 0.06 418 (21) 0.001
Unstable angina pectoris/NSTEMI 20 (30) 24 (36) 0.46 790 (39) 0.15
STEMI 3 (5) 3 (5) 1.00 288 (14) 0.009
Atypical angina 5 (8) 1 (2) 0.09 57 (3) 0.06
Other/unknown 11 (16) 0 (0) 0.01 486 (23) 0.18
Past interventions
PCI 39 (59) 18 (27) 0.001 985 (48) 0.07
CABG 3 (5) 4 (6) 1.00 172 (8) 0.11
PCI and CABG 10 (15) 5 (8) 0.17 144 (7) 0.02
Use of pressure wire 10 (15) 5 (8) 0.17 69 (3) 0.01
Use of IVUS 23 (35) 8 (12) 0.002 101 (5) 0.049
Irradiation treatment for in stent restenosis 3 (5) 0 (0) 0.08 0 (0) 0.001
Use of high-speed rotational atherectomy 1 (2) 0 (0) 0.33 3 (0.1) 0.03
Vessel territory* 0.42
LAD 32 (48) 29 (44)
RCA 21 (32) 25 (39)
LCX 25 (38) 19 (29)
Grafts 6 (9) 2 (3)
Lesions treated, n 0.31
0 1 (2) 0 (0)
1 31 (47)† 42 (63)
2 18 (27) 18 (27)
3 9 (14) 5 (8)
4 2 (4) 1 (2)
5 1 (2) 0 (0)
Values are n (%). The characteristics of the patients who underwent live transmission coronary procedures are compared with our routine 2010
experience and 66 matched controls. *More than 1 territory was treated in several patients. †A combined procedure was done in 3 patients.
CABG coronary artery bypass grafting; IHD ischemicheart disease; IVUS intravascular ultrasound; LCX left circumflex coronary artery; LMCA left
main coronary artery; NSTEMI non–ST-segment elevation myocardial infarction; PCI percutaneous coronary intervention; STEMI ST-segment elevationmyocardial infarction;VDvesseldisease;otherabbreviationsas inTable1.
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220Overall, the 1-year event rate free of major events (death,
MI, stroke, repeat revascularization) in all patients treated
during live case demonstration was 97%.
Mayo Clinic Risk Score
The Mayo Clinic Risk Score (MCRS) (9) has 7 simple
clinical and diagnostic variables for predicting in-hospital
mortality after PCI. The distribution of the MCRS of the
coronary patients in the present study was Gaussian (Fig. 2).
Table 3. Comparison Between Coronary Study Group and Matched Controls
Live
Transmission
(n  66)
Matched
Controls
(n  66) RR (95% CI) p Value
In-hospital
Death, MI, stroke 1 3 0.32 (0.02–3.62) 0.62
Death 0 0
Stroke 0 0
MI 1 3
Unsuccessful 5 3 1.72 (0.33–9.57) 0.72
Minor complication 6 4 1.55 (0.36–6.98) 0.74
Discharge to 30 days
Death, MI, stroke,
repeat intervention
1 0 4.42 (0.17–77.7) 1.0
Death 0 0
Stroke 0 0
MI 1 0
Repeat intervention 1 0
CI confidence interval; MImyocardial infarction; RR relative risk.
Figure 1. Study Interventions and SuccessEPS  electrophysiological study; TAVI  transcatheter aortic valve implantation.The MCRS of 50% of the patients was between 1 and 5,
and 40% of the patients had a score between 5 and 8, which
correlated to a predicted mortality rate of 2% to 5%. There
were no deaths in this cohort of patients.
Comparison to Routine Practice,
Non–Live-Transmission Procedures
When we compared the results of the live-transmission
coronary patients to our daily experience and patient mix
undergoing coronary procedures during 1 year (2010), we
observed that baseline characteristics of the 2010 cohort
were similar to the present study group with regard to sex,
age, and most risk factors. However, not surprising, the
live-transmission group presented more often with stable
angina compared with the more acute coronary syndromes
in daily non–live-transmission cases. In the live-transmission
group, there was a more frequent use of intravascular ultra-
sound and pressure wire (Table 2).
Matched Controls
We compared our study patients to a corresponding
matched control group, all from the 2010 cohort (Table 2).
The groups were well matched with regard to sex, age, risk
factor profile, disease severity, and symptoms.
In the matched control group, there were no in-hospital
deaths or strokes, but there were 3 cases of post-intervention
myocardial infarction. The primary endpoint of the study
was not different between the study group and the matched
score
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221controls: RR: 0.32; 95% CI: 0.02 to 3.62; p  0.62 (Table 3).
The success rate was not different between the study group and
the matched controls: RR: 1.72; 95% CI: 0.33 to 9.57; p 
0.72. There were 3 cases in which the procedure was unsuc-
cessful (all due to CTOs) out of 7 CTOs attempted in the
matched control group (success rate of 57%).
Minor and other complications in the matched controls
included 2 cases of VF, 1 during a primary PCI, 1 access site
bleeding, and 1 post-procedure shock. There were 2 cases
with type C dissections sealed successfully with stents.
There were no perforations. The rate of minor complica-
tions was not different: RR: 0.31; 95% CI: 0.04 to 1.81; p
0.27.
During the 30-day follow-up, which was available for all
patients in the matched control group, there were no deaths
or strokes. During this period, repeat coronary angiography
was performed in 1 patient due to symptoms without any
significant findings. The secondary endpoints at 30 days
were similar in both groups: RR: 0.42; 95% CI: 0.17 to 7.17;
p  0.97.
Discussion
Live case demonstrations to individuals and to training
groups are the heart of teaching surgical and interventional
techniques. Transmission of these demonstrations to a large
audience with interactive discussion between the operators
and the audience opens the procedural details to criticism,
allows better training, advances the practice and science of
medicine, accelerates the diffusion of new technologies, and
promotes the adoption of innovations. Such courses with
live case transmission also inform the health professionals
Figure 2. Distribution of the Study Coronary Patients According to the May
The percentages represent the expected in-hospital mortality according to theon newly available interventions.Transmission also enables immediate feedback from large
groups of experienced physicians and may thus even im-
prove the quality of patient care. Indeed, in the current
study, 4 planned procedures were not performed after
further discussions with the panel. There were cases
where discussions with the panel led to changes of the
intended plan. One example is the diagnosis of a carotid
stenosis in the external carotid artery, and another
example is the decision to send a patient to surgery rather
than perform PCI. There were cases where the length of
the stent and the type of stent or procedure were
discussed, and the plan was somewhat modified. We
found that often this discussion with an expert panel with
diverse opinions is highly challenging, but often with
excellent educational value, both to the performing op-
erators as well as to the audience.
Nonetheless, reservations and even opposition to the
broadcasting of live demonstrations have been raised due to
the potential increased risk for the patients (8). We have
found from our long-term, multiyear experience that
procedures that were done by experienced operators in
conjunction with expert panel discussions while being
broadcast are safe and are not associated with an in-
creased rate of major complications. In the present study,
the procedure was free of major complications in 98% of
the treated patients, and the complete or partial success
rate was 93%. This clinical success was not different from
that found in daily practice (2).
There are substantial obstacles during live case transmis-
sions, such as distraction of the operator by the panel and
audience discussions, timing issues due to the limited
transmission time windows, or the occasional requirement
ic Risk Score for Mortality Prediction
. Most patients (n  46, 70%) were within a score between 3 and 6.o Clinto pause the procedure until the transmission is online.
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222Other possible difficulties are the use of novel investiga-
tional devices and the presence of hindering transmission
equipment in the catheterization laboratory. Collectively,
these obstacles may lead to a stressful environment for the
operators and the team. In the present study, we report that
9% of patients experienced a minor complication during the
procedure. However, events, such as VF or allergic reac-
tions, can also occur during an interventional procedure, and
usually are not even mentioned as a complication in most
randomized trials (2).
Although live case transmissions are a powerful educa-
tional tool, they also involve organizational and economic
challenges, and may provide secondary gain regarding sci-
entific and industrial influence and prestige. Furthermore,
there are no objective measures of the educational value of
observing live case demonstrations, and there is a paucity of
data on the potential safety to patients who are treated
during live case demonstrations.
Although there are now numerous courses in which the
transmission of live case demonstrations is part of the
meeting, and many patients underwent procedures in live
transmission, there is a lack of published data on this topic.
Data on the outcomes of live case demonstrations are limited
to what is shown during the transmission, and there are no
reports of the short- and long-term outcomes in these
atients. Only rarely, anecdotal follow-up reports on the
utcome of the patients that were treated during live case
emonstrations are presented at subsequent meetings.
In 1992, Chatelain et al. (5) published the first report of
esults of live case demonstrations and transmission in
ardiac patients in the Lancet. Among 104 coronary angio-
plasty procedures that were demonstrated live in 12 inter-
national angioplasty courses during 1991, only 73% of the
initially planned procedures were successful. This success
rate increased to 93% when the crossover to another device
was included. Threatened occlusions occurred in 10%, acute
occlusions in 6%, and delayed occlusions in 2% of all cases.
No deaths or MIs were reported. Based on their results,
Chatelain et al. concluded that “real results of coronary
angioplasty are inferior to those found in publications”;
furthermore, “interventions done before an audience will be
unusually stressful but this will be outweighed by the fact
that difficult cases with a low probability of success are rarely
tackled during live courses.” In contrast to the lesions that
were treated in 1991, the cases that we chose to transmit in
the present study were typically with more complex coro-
nary artery disease. Yet, the success and complication rates
were similar to routine practice and are within the current
accepted standards in the literature (2).
Surprisingly, we found no published peer-reviewed pa-
pers on live demonstrations until 2009, when Franke et al.
(4) described 186 patients treated live by carotid stenting. In
this consecutive series of carotid stent cases that were done
by expert operators from 3 high-volume centers during livedemonstration courses, the procedural and 30-day clinical
outcomes were similar to the results that appeared for
non–live-transmission results in the contemporary pub-
lished data. The findings by Franke et al. (4) are opposite to
those that were reported by Chatelain et al. (5), and provide
evidence of no harm to patients broadcast during live case
demonstrations. In an accompanying editorial, MacKay
wrote, “Whether the drama of live broadcasts has an
educational or other advantage over staged recording of
procedures is still to be determined” (3).
Over the past 20 years, the Transcatheter Cardiovascular
Therapeutics conference has broadcast 928 live cases from
101 clinical sites, both inside and outside the United States
(7). Although many of these cases were high-risk patients or
patients with complex anatomy, only 2 procedure-related
deaths occurred during these broadcasts. This mortality rate of
0.21% (95% confidence limits: 0.03% to 0.88%) is a rate that is
well within acceptable standards for such procedures (9,10).
The Ethics Committee of the American Association for
Thoracic Surgery and the Standards and Ethics Committee
of the Society of Thoracic Surgeons (8) have highlighted
patient safety and risks and questionable medical ethics that
are associated with live case demonstrations. Although these
2 committees recognized that the teaching of surgical
techniques by direct observation of live surgery in the
surgeon’s home operating theater is a time-honored accept-
able practice, they concluded that the educational benefits of
broadcast live case demonstrations are meager when com-
pared with the potential harms that are faced by the
participating patient. Thus, these 2 committees have rec-
ommended that national and international cardiothoracic
societies consider prohibiting live surgery broadcasts at their
annual meetings (13).
Recently, several cardiology associations wrote a state-
ment on the use of live case demonstrations at cardiology
meetings (7). They attest to the inherent, but difficult to
measure, benefits of live case demonstrations for physician
education, improved quality of medical care, increased
enrollment in clinical trials, and fostering innovations in
medical device development. The writing committee sum-
marizes as follows: “After evaluating the pros and cons of
live case demonstrations and the available data, the writing
committee cannot determine if the educational benefits of
live case demonstrations outweigh any potential negative
consequences.” The statement presents also a detailed list of
measures that are aimed at mitigating patient risks and
ethical concerns. The recommendations also describe mech-
anisms for standardizing the performance of live case
demonstrations to enhance patient safety and improve their
educational value, and present a code of conduct (7). These
recommendations also include a suggestion that an ongoing
registry of live case demonstrations be established. The
purpose of this registry is to collect objective information to:
1) determine the educational value of live case demonstra-
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223tions; 2) enable the assessment of immediate, short-term,
and long-term patient outcomes; 3) monitor operator and
course behavior; and 4) permit review of the feedback from
the audience participants.
As a public health regulatory agency, the Food and Drug
Administration (FDA) has important oversight of many
aspects of live case demonstrations. The FDA has also
published its opinion on live case presentations in interven-
tional cardiology (7), stating that their focus is on patient
safety and outcomes of patients who participate in live case
demonstrations, clinical trial integrity, and improper med-
ical device promotion. Use of investigational devices in live
case demonstrations is subject to review and approval by the
FDA’s Center for Devices and Radiological Health. The
agency issues Investigational Device Exemptions for devices
to be used in these meetings. In order to improve follow-up
of these patients, the FDA is now considering developing
further guidance on live case presentations during Investi-
gational Device Exemption clinical trials. In fact, the agency
has called for more research on procedural safety outcomes
during live case presentations to better define patient risks,
particularly at a time when live case presentations have become
a cornerstone of many interventional cardiology meetings.
Our report is a single-center experience of 101 consecu-
tive patients who underwent transcatheter cardiovascular
interventions under conditions of live case demonstrations.
The data inform on the safety of the procedure, the success
rate, and the long-term clinical outcomes. It is clear that the
selected group of patients were challenging cases that are
not the usual daily practice in the catheterization laboratory.
This is seen in the relatively high-risk score of our patients
according to the MCRS. The fact that all the failures were
due to coronary CTOs is biased by the selection of the
complex cases for the demonstration purposes.
Study limitations. Being a retrospective, highly selective
egistry, our findings are obviously limited to the nature of
uch a collection of patients. Although different interven-
ions, which were indiscriminately grouped, were done in
atients, the common denominator for all these patients is
hat each underwent a transcatheter cardiovascular interven-
ion under live case transmission conditions. It should be
mphasized that the cases in the live transmission group
ere highly selective mainly regarding anatomy and proce-
ure complexity and were chosen after immense screening.
inding matched controls is complex and difficult. The 95%
I around the RR for the rates of adverse events between
he live case and control groups were sufficiently wide that
eaningful relative differences between them cannot be
ompletely excluded. The outcome analysis is unadjusted as
he low event rates limit the statistical power of such
djustment. Larger series of live case transmissions are
eeded. Finally, the present results apply only to those from
ur center; whether the safety and patient outcomes fromive case demonstrations performed from other institutions
s similar, superior or inferior to these results is unknown.
onclusions
Our report presents evidence that support the view that
patient safety is not jeopardized when an interventional
cardiology procedure is done as a live case demonstration.
Although the audience can see, hear, interact with, and
experience all aspects of the case as it is performed, the
procedure is not associated with a worse outcome, as judged
by the results that are presented in this report. There are
potential gains of using communication technology to
enhance education. Live case demonstration may even
provide a more controlled environment for online decisions
during the interventions. Our findings support the notion
that for patients who are carefully selected and treated by an
experienced team, the stressful conditions that are associ-
ated with live case transmissions do not jeopardize patient
safety and procedural efficiency.
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